Single agent combination chemotherapy in the adjuvant therapy for pancreatic cancer: 2nd vote and conclusions

Date 10 September 2017
Event ESMO 2017 Congress
Session Single agent or combination chemotherapy in the adjuvant therapy for pancreatic cancer
Topics Cytotoxic agents
Pancreatic Cancer
Gastrointestinal Cancers
Therapy
Biological therapy
Presenter Thomas Seufferlein
Authors T. Seufferlein
  • Department Of Internal Medicine I  , Ulm Medical University, 89081 - Ulm/DE